Real-life impacts of olipudase alfa: experiences of adults receiving enzyme replacement therapy for acid sphingomyelinase deficiency-results from an international survey study.

Morsy AS, Mbua S, Mathieson T, Hopkin J, Bolton S

Open source

DOI
10.1186/s13023-025-03997-6
Published
2025 Sep 30
Container
Orphanet journal of rare diseases
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-025-03997-6,
  title = {Real-life impacts of olipudase alfa: experiences of adults receiving enzyme replacement therapy for acid sphingomyelinase deficiency-results from an international survey study.},
  author = {Morsy AS and Mbua S and Mathieson T and Hopkin J and Bolton S},
  year = {2025},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-025-03997-6},
  url = {https://doi.org/10.1186/s13023-025-03997-6}
}

RIS

TY  - JOUR
TI  - Real-life impacts of olipudase alfa: experiences of adults receiving enzyme replacement therapy for acid sphingomyelinase deficiency-results from an international survey study.
AU  - Morsy AS
AU  - Mbua S
AU  - Mathieson T
AU  - Hopkin J
AU  - Bolton S
PY  - 2025
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-025-03997-6
UR  - https://doi.org/10.1186/s13023-025-03997-6
ER  - 

APA

AS, M., S, M., T, M., J, H., & S, B. (2025). Real-life impacts of olipudase alfa: experiences of adults receiving enzyme replacement therapy for acid sphingomyelinase deficiency-results from an international survey study.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-025-03997-6

Source records